Shandong Lukang Pharmaceutical Co Ltd (600789) — Cash Flow Quality Index
Shandong Lukang Pharmaceutical Co Ltd (600789) has a Cash Flow Quality Index of -0.19x as of September 2025. Operating cash flow of CN¥-6.39 Million is below net income of CN¥34.36 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 600789 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shandong Lukang Pharmaceutical Co Ltd Cash Flow Quality Index (1998–2025)
Historical Cash Flow Quality Index for Shandong Lukang Pharmaceutical Co Ltd across 24 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Shandong Lukang Pharmaceutical Co Ltd (600789) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Shandong Lukang Pharmaceutical Co Ltd (1998–2025)
Year-by-year earnings quality comparison for Shandong Lukang Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see 600789 market cap.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 6.22x | CN¥698.17 Million | CN¥112.30 Million | ▲ +530.2% |
| 2024 | 0.99x | CN¥402.82 Million | CN¥408.35 Million | ▼ -59.8% |
| 2023 | 2.45x | CN¥604.01 Million | CN¥246.17 Million | ▼ -21.0% |
| 2022 | 3.11x | CN¥444.38 Million | CN¥143.12 Million | ▲ +73.6% |
| 2021 | 1.79x | CN¥149.33 Million | CN¥83.48 Million | ▲ +78.1% |
| 2020 | 1.00x | CN¥234.55 Million | CN¥233.49 Million | ▼ -64.2% |
| 2019 | 2.81x | CN¥361.87 Million | CN¥128.79 Million | ▲ +38.8% |
| 2018 | 2.02x | CN¥351.09 Million | CN¥173.43 Million | ▼ -5.3% |
| 2017 | 2.14x | CN¥275.51 Million | CN¥128.93 Million | ▼ -78.7% |
| 2016 | 10.04x | CN¥296.23 Million | CN¥29.51 Million | ▼ -3.0% |
| 2015 | 10.35x | CN¥78.39 Million | CN¥7.57 Million | ▼ -83.4% |
| 2013 | 62.42x | CN¥256.50 Million | CN¥4.11 Million | ▲ +853.1% |
| 2011 | 6.55x | CN¥123.28 Million | CN¥18.82 Million | ▲ +183.8% |
| 2010 | 2.31x | CN¥308.88 Million | CN¥133.83 Million | ▼ -52.9% |
| 2009 | 4.90x | CN¥199.49 Million | CN¥40.68 Million | ▼ -9.1% |
| 2008 | 5.40x | CN¥209.39 Million | CN¥38.80 Million | ▲ +2.6% |
| 2007 | 5.26x | CN¥137.30 Million | CN¥26.10 Million | ▼ -83.8% |
| 2005 | 32.48x | CN¥161.64 Million | CN¥4.98 Million | ▲ +949.8% |
| 2003 | 3.09x | CN¥167.42 Million | CN¥54.12 Million | ▼ -4.3% |
| 2002 | 3.23x | CN¥315.59 Million | CN¥97.62 Million | ▼ -15.8% |
| 2001 | 3.84x | CN¥270.43 Million | CN¥70.46 Million | ▲ +925.8% |
| 2000 | 0.37x | CN¥22.36 Million | CN¥59.76 Million | ▼ -50.7% |
| 1999 | 0.76x | CN¥35.12 Million | CN¥46.27 Million | ▼ -1.0% |
| 1998 | 0.77x | CN¥46.18 Million | CN¥60.22 Million | — |